David Colleran - 11 Mar 2024 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
EVP, General Counsel, Corp Sec
Signature
/s/ David Colleran
Issuer symbol
ANIK
Transactions as of
11 Mar 2024
Net transactions value
-$126,306
Form type
4
Filing time
12 Mar 2024, 20:03:49 UTC
Previous filing
14 Mar 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Options Exercise $0 +3,682 +17% $0.000000 24,804 11 Mar 2024 Direct F1, F2
transaction ANIK Common Stock Tax liability $27,479 -1,081 -4.4% $25.42 23,723 11 Mar 2024 Direct F3, F4
transaction ANIK Common Stock Options Exercise $0 +5,465 +23% $0.000000 29,188 11 Mar 2024 Direct F5
transaction ANIK Common Stock Tax liability $40,799 -1,605 -5.5% $25.42 27,583 11 Mar 2024 Direct F4, F6
transaction ANIK Common Stock Options Exercise $0 +7,662 +28% $0.000000 35,245 11 Mar 2024 Direct F7
transaction ANIK Common Stock Tax liability $58,028 -2,250 -6.4% $25.79 32,995 11 Mar 2024 Direct F8, F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIK Restricted Stock Unit Options Exercise $0 -3,682 -100% $0.000000* 0 11 Mar 2024 Common Stock 3,682 $0.000000 Direct F10
transaction ANIK Restricted Stock Unit Options Exercise $0 -5,465 -33% $0.000000 10,930 11 Mar 2024 Common Stock 5,465 $0.000000 Direct F11
transaction ANIK Restricted Stock Unit Options Exercise $0 -7,662 -50% $0.000000 7,663 11 Mar 2024 Common Stock 7,662 $0.000000 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
F2 Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 642 shares on May 12, 2023 and 192 shares on November 14, 2023.
F3 Reflects an aggregate of 1,081 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
F4 Reflects the closing price of ANIK common stock on March 8, 2024, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
F5 Reflects the first vesting installment of RSUs granted on March 9, 2023.
F6 Reflects an aggregate of 1,605 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2024.
F7 Reflects the second vesting installment of RSUs granted on March 11, 2022.
F8 Reflects an aggregate of 2,250 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2024.
F9 Reflects the closing price of ANIK common stock on March 11, 2024, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
F10 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.
F11 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
F12 Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023.